Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma

Author： Sharma Bhawna Singh Seema Varney Michelle L Singh Rakesh K

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.4, 2010-04, pp. : 435-442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1574-1589

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1427-1440

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR2 Receptor Antagonists: A Medicinal Chemistry Perspective

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1590-1605

Bentham Science Publishers

Access to resources Recommend Favorite

Novel pyrimidine-based CXCR2 chemokine receptor antagonists

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 10, 2004-10 ,pp. : 1507-1510

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-01 ,pp. : 1345-1352

Bentham Science Publishers

Access to resources Recommend Favorite